Factors influencing adherence to paediatric antiretroviral therapy in Portharcourt, South- South Nigeria

Pan African Medical Journal

Volumn 16, Issue , 2013, Pages

  Ugwu, Rosemary ^a   Eneh, Augusta ^a  

^a UNIVERSITY OF PORT HARCOURT   (Nigeria)

Author keywords

Adherence; Antiretroviral therapy; Children; HIV; Nigeria; Port Harcourt; Self report

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ PLUS LAMIVUDINE PLUS ZIDOVUDINE; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; LAMIVUDINE PLUS LOPINAVIR PLUS RITONAVIR; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS ZIDOVUDINE;

ADOLESCENT; ADULT; AGE; ANTIVIRAL THERAPY; ARTICLE; CAREGIVER; CHILD; CHILD HEALTH CARE; COMORBIDITY; CROSS-SECTIONAL STUDY; EDUCATIONAL STATUS; FAMILY CONFLICT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; NIGERIA; PATIENT COMPLIANCE; PREDICTION; PRESCHOOL CHILD; SCHOOL CHILD; SELF REPORT; SLEEP; SOCIAL STATUS; TRAVEL; TREATMENT OUTCOME; TREATMENT REFUSAL; VOMITING;

EID: 84886261925     PISSN: 19378688     EISSN: None     Source Type: Journal    
DOI: 10.11604/pamj.2013.16.30.1877     Document Type: Article

References (25)

1. Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. 2011 Available at http://aidsinfo.nih.gov/ContentFiles/PediatricGuidelines.pdf. Accessed 20 March 2012.
2. Paterson DL, Swindells S, Mohr J et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21-30.
3. Watson DC, Farley JJ. Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1. Pediatr Infect Dis J. 1999; 18(8):682-689.
4. Steele RG, Grauer D. Adherence to antiretroviral therapy for pediatric HIV infection: review of the literature and recommendations for research. Clin Child Fam Psychol Rev. 2003; 6(1):17-30.
5. Gifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, Bozzette SA. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr. 2000;23(5):386-395.
6. Murphy DA, Wilson CM, Durako SJ, Muenz LR, Belzer M. Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS Care. 2001; 13(1):27-40.
7. Reddington C, Cohen J, Baldillo A et al. Adherence to medication regimens among children with human immunodeficiency virus infection. Pediatr Infect Dis J. 2000; 19(12):1148-1153.
8. Bangsberg DR, Perry S, Charlebois ED et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001; 15(9): 1181-1183.
9. Monjok E, Smesny A, Okokon IB, Mgbere O, Essien EJ. Adherence to antiretroviral therapy in Nigeria: an overview of research studies and implications for policy and practice. HIV/AIDS-Research and Palliative Care. 2010;2: 69-76.
10. Nwauche CA, Erhabor O, Ejele OA, Akani CI. Adherence to antiretroviral therapy among HIV-infected subjects in a resource limited setting in the Niger Delta of Nigeria. Afr J Health Sci. 2006;13(3?4):13-17.
11. Uzochukwu BSC, Onwujekwe OE, Onoka AC, Okoli C, Uguru NP, Chukwuogo OI. Determinants of non-adherence to subsidized anti-retroviral treatment in southeast Nigeria. Health Policy Plan. 2009;24(3):189-196.
12. Oyedeji GA. Socio-economic and cultural background of hospitalized children in Ilesha. Nig J Paed. 1985;12:111-117.
13. Amberbir A, Woldemichael K, Getachew S, Girma B, Deribe K. Predictors of adherence to antiretroviral therapy among HIV-infected persons: a prospective study in Southwest Ethiopia BMC Public Health. 2008, 8:265.
14. Mukhtar-Yola M, Adeleke S, Gwarzo D, Ladan ZF. Preliminary investigation of adherence to antiretroviral therapy among children in Aminu Kano Teaching Hospital, Nigeria. Afr J AIDS Res. 2006;5(2):141-144.
15. Gordillo V, del Amo J, Soriano V, González-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS. 1999;13(13):1763-1769.
16. Machtinger EL, Bangsberg DR. Adherence to HIV antiretroviral therapy. HIV In Site Knowledge Base Chapter. 2005. Available at http:hivinsite.ucsf.edu/InSite?page=kb-03-02-09. Accessed 21 March 2012.
17. Wang X, Wu Z. Factors associated with adherence to antiretroviral therapy among HIV/AIDS patients in rural China. AIDS. 2007;21(suppl 8): S149-S155.
18. White YRG, Pierre RB, Steel-Duncan J et al. Adherence to antiretroviral drug therapy in children with HIV/AIDS in Jamaica. West Indian Med J. 2008; 57(3): 231-237.
19. Potchoo Y, Tchamdja K, Balogou A, Pitche VP, Guissou IP, Kassang EK. Knowledge and adherence to antiretroviral therapy among adult people living with HIV/AIDS treated in the health care centers of the association "Espoir Vie Togo" in Togo, West Africa. BMC Clinical Pharmacology. 2010; 10:11
20. Weiser S, Wolfe W, Bangsberg D, et al. Barriers to Antiretroviral Adherence for Patients Living with HIV Infection and AIDS in Botswana. J Acquir Immune Defic Syndr. 2003;34(3):281-288.
21. Belzer ME, Fuchs DN, Luftman GS, Tucker DJ. Antiretroviral adherence issues among HIV-positive adolescents and young adults. J Adolesc Health. 1999; 25(5):316-9.
22. Eneh AU, Ugwu RO. Paediatric HIV at the University of Port Harcourt Teaching Hospital, Port Harcourt. Nig J Paed. 2007;34:24-30.
23. Müller AD, Bode S, Myer L, Stahl J, von Steinbüchel N. Predictors of adherence to antiretroviral treatment and therapeutic success among children in South Africa. AIDS Care. 2011;23(2):129-138.
24. Orrell C, Bangsberg DR, Badri M, Wood R. Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS. 2003; 17(9): 1369-1375.
25. Wessels X, Nattrass N, Rivett U. Improving the efficiency of monitoring adherence to antiretroviral therapy at primary health care level: a case study of the introduction of electronic technologies in Guguletu, South Africa. Development Southern Africa. 2007;24(4): 607-621.